This June, Purdue Pharma (Canada) joins all of those celebrating Cancer Survivors Month in Canada, and around the world. Since 2016, Canadians have been taking pause during the month of June to reflect on how cancer has affected our lives, the lives of people we know, and to celebrate the survivors who remain with us because of innovative research and treatments.
In April, we shared Purdue Pharma (Canada)’s commitment to finding solutions for cancer patients to treat and live with pain caused by their disease, procedure or treatment, and chemotherapy induced nausea and vomiting.
According to the Canadian Cancer Society, based on 2006-2008 estimates, over 60% of Canadians diagnosed with cancer are expected to survive for 5 years or more after a cancer diagnosis. And, between 1992-1994 and 2006-2008, survival rates increased from 53% to 60%. This is an important statistic, especially if you go back even further to the 1940s when the 5-year survival rate was a mere 25%. And while we cannot lose sight of the men and women who die due to cancer every day, today is about celebrating those who are still living with cancer and are in our homes, in our workplaces, in our communities, and in our lives.
All of these statistics prove that collectively, we are moving in the right direction when it comes to cancer research and treatment options. And Purdue Pharma (Canada) takes our role in helping to improve the quality of life of cancer patients very seriously.
Today, we focus on the cancer survivors. Tomorrow, we get back to the hard work of ensuring we have more survivors in the months and years to come.